Key facts
- Notable investors include CICC Capital, Heda Ventures, Ming Bioventures, Plainever Investment & Management, Weiyi Venture Capital (Suzhou).
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Innocardiac Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Innocardiac Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Innocardiac Medical
Manufacturer of implantable artificial biomedical devices designed for disease treatment. The company's products include artificial biological heart valves, artificial heart valvuloplasty rings, and tissue fixators, enabling the advanced treatment of cardiovascular disease in the medical industry.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2008
- Employees
- 40
- Website
- innocardiac.com/
- Ownership
- Privately Held (backing)
Innocardiac Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innocardiac Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innocardiac Medical in its N-PORT filings yet. We sweep new filings monthly.